Robert C. Robbins, M. D.

Back to Profile

Publication Details

  • The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

    Hua X, Deuse T, Chen YJ, Wulff H, Stubbendorff M, Köhler R, Miura H, Länger F, Reichenspurner H, Robbins RC, Schrepfer S. Transplantation. 2013; 95 (2): 285-92

    The calcium-activated potassium channel KCa3.1 is critically involved in T-cell activation as well as in the proliferation of smooth muscle cells and fibroblasts. We sought to investigate whether KCa3.1 contributes to the pathogenesis of obliterative airway disease (OAD) and whether knockout or pharmacologic blockade would prevent the development of OAD.

    PubMedID: 23325003

Stanford Medicine Resources:

Footer Links: